NEW YORK (GenomeWeb) – Investment bank William Blair today upgraded its rating for Sequenom's shares to Outperform on expectations of continued adoption of the molecular diagnostic firm's non-invasive prenatal testing technology and recent business developments that could increase revenues.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.